UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo Journal article
Liu, Manting, Huang, Wensou, Guo, Yongjian, Zhou, Yubo, Zhi, Cheng, Chen, Jingwu, Li, Junping, He, Jinping, Lian, Hui, Zhou, Jingwen, Ye, Xiaodie, Hu, Yuling, Hu, Hong, Liu, Zhaoyuan, Huang, Jingjun, Lin, Liteng, Cai, Mingyue, Wang, Xiaobin, Huang, Jingzhen, Zhang, Zhenfeng, Zhu, Kangshun, Zhao, Qi, Cao, Bihui. CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo[J]. Journal of Leukocyte Biology, 2022, 112(4), 901-911.
Authors:  Liu, Manting;  Huang, Wensou;  Guo, Yongjian;  Zhou, Yubo;  Zhi, Cheng; et al.
Favorite | TC[WOS]:38 TC[Scopus]:35  IF:3.6/5.2 | Submit date:2022/05/17
Chimeric Antigen Receptor  Delta-like Ligand 3  Nk-92 Cells  Sclc  
Development of mesothelin-specific car nk-92 cells for the treatment of gastric cancer Journal article
Cao, Bihui, Liu, Manting, Huang, Jingjun, Zhou, Jingwen, Li, Junping, Lian, Hui, Huang, Wensou, Guo, Yongjian, Yang, Shuo, Lin, Liteng, Cai, Mingyue, Zhi, Cheng, Wu, Jingqiang, Liang, Licong, Hu, Yuling, Hu, Hong, He, Jinping, Liang, Baoxia, Zhao, Qi, Zhu, Kangshun. Development of mesothelin-specific car nk-92 cells for the treatment of gastric cancer[J]. International Journal of Biological Sciences, 2021, 17(14), 3850-3861.
Authors:  Cao, Bihui;  Liu, Manting;  Huang, Jingjun;  Zhou, Jingwen;  Li, Junping; et al.
Favorite | TC[WOS]:50 TC[Scopus]:46  IF:8.2/8.3 | Submit date:2022/05/13
Chimeric Antigen Receptor  Gastric Cancer  Mesothelin  Nk-92  Pdx  
Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer Journal article
Yang,Shuo, Cao,Bihui, Zhou,Guangyu, Zhu,Lipeng, Wang,Lu, Zhang,Li, Kwok,Hang Fai, Zhang,Zhenfeng, Zhao,Qi. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer[J]. Frontiers in Pharmacology, 2020, 11, 1089.
Authors:  Yang,Shuo;  Cao,Bihui;  Zhou,Guangyu;  Zhu,Lipeng;  Wang,Lu; et al.
Favorite | TC[WOS]:45 TC[Scopus]:48  IF:4.4/5.0 | Submit date:2021/03/04
B7-h3  Chimeric Antigen Receptor  Immune Checkpoint  Natural Killer Cell  Nk-92